This program is not affiliated with the official program of Academy 2023
Join the excitement with this 75-minute education program for optometrists, where learning about cataract patient co-management meets the fun of Family Feud!
Dive into crucial topics with the thrill of a game show, sparking lively debates and interactive discussions. From patient expectations to communication strategies, this isn't just another professional seminar -- it's a spirited competition that promises laughter, learning, and fresh approach to optometric practice success!
|6:45 pm CT||Introduction and Audience Polling|
|6:50 pm CT||
Game Round 1: Expectations & Impacts
Objective: Discuss the outcomes expectations of refractive IOL patients according to optometrists
Discussion: The impacts of unhappy refractive patients on an optometric comanaging practice
|7:05 pm CT||
Game Round 2: Diagnosis Showdown
Objective: Define best practices for diagnosing key comorbid conditions.
Discussion: The impacts of comorbid conditions on surgical outcome and patient satisfaction.
|7:35 pm CT||
Game Round 3: Communication Challenge
Objective: Identify best practices for interacting with refractive IOL patients and comanaging surgeons.
Discussion: The impact these best practice communications have on patient expectations, satisfaction, and referral rates.
|7:50 pm CT||Wrap-Up, Q&A, and Audience Polling|
|8:00 pm CT||Program Concludes|
Grant Support Statement
This activity is supported by unrestricted educational grants from Horizon Therapeutics, Johnson & Johnson Vision, and Tarsus Pharmaceuticals, Inc.
The Fundingsland Group, LLC is a COPE-Approved Administrator.
Both the synchronous in-person and synchronous virtual activities are accredited by COPE for continuing education for optometrists.
Synchronous In-Person: COPE Activity 126744, COPE Course 86198-PO Synchronous Virtual: COPE Activity 126745, COPE Course 86204-PO
The activities are for approved for 1.25 hours of CE each. COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Financial Relationship Disclosure
Jacob Lang, OD, FAAO, Planner & Faculty Member, has relevant financial relationships as a consultant for: Allergan, AOS, Avellino, Dompe, Horizon, Kala, Novartis, Orasis, Oyster Point, Quidel, and Tarsus. He is a consultant and speaker for Sun Pharma.
Selina McGee, OD, FAAO, Planner & Faculty Member, has the following relevant financial relationships: Consultant: Alcon, Aldeyra, Bruder, Horizon, and Novartis; Consultant & Speaker: Allergan, Avellino, Bausch + Lomb, Cynosure, and Dompe.
Jade Coats, OD, Faculty Member, has relevant financial relationships as a consultant for: Novaliq, Orasis, and Zeiss. She is a consultant and speaker for: Oyster Point, Tarsus, and Thea. Dr. Coats is a speaker for Basuch + Lomb, Dompe, Kala, and Sun Pharma.
Nathan Lighthizer, OD, FAAO, Faculty Member, has relevant financial relationships as a consultant for: Allergan, Ellex, Eyepromise, iCare, Orasis, and SightSciences. He is a consultant and speaker for: Bausch + Lomb. Dr. Lighthizer is a speaker for: Allergan, Dompe, Innova Systems, and Lumenis.
Carolyn Majcher, OD, FAAO, Faculty Member, has relevant financial relationships as a consultant for: Apellis, Notal Vision, Ocuterra, and Optomed. She is a consultant and speaker for Iveric Bio, Regeneron, and Zeiss. Dr. Majcher has a non-financial relationship (writing assistance) with Roche. Additionally, she has disclosed a non-relevant consultant relationship with LENZ Therapeutics.
Justin Schweitzer, OD, FAAO, Faculty Member, has relevant financial relationships as a consultant and speaker with Alcon, Allergan, Bausch + Lomb, Dompe, Glaukos, LKC, SightSciences, Sun Pharma, Tarsus, and Zeiss. He is a consultant for: Avellino, EyePoint, Iveric Bio, Mediprint, Occuphire, Reichert, and Visus. Dr. Schweitzer has also disclosed a non-relevant relationship as a consultant with Modern Optometry.
Mark Schaeffer, OD, Faculty Member, has relevant financial relationships as a consultant for: Aescula Tech, Alcon, Allergan, Bausch + Lomb, CooperVision, Optase, ScienceBased Health, SightSciences, and Tarsus.
All TFG staff and planners have affirmed they maintain no financial relationships with COPE-defined ineligible companies.
It is the policy of The Fundingsland Group (TFG) that faculty and other individuals in a position to control content of this activity disclose all financial relationships with COPE-defined ineligible companies within the past 24 months. TFG has policies in place that have identified relevant relationships and mitigated any real or apparent conflicts of interest prior to this educational activity.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The objective of TFG in developing continuing medical education activities is to promote the free expression and interchange of ideas and information for educational purposes. TFG does not accept responsibility for any opinions, positions, or statements contained or expressed in such material, and such opinions, positions and statements are not necessarily those of the TFG. Courses are intended to provide instruction leading to new knowledge and/or skills. TFG does not certify competence upon completion of the courses. The information presented is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.